Provider of a wearable device for breathing monitoring. It monitors the sound of the lungs and alerts the user of the wheezing sounds. This allows the user to manage their symptoms at an early stage and avoid the risk of asthma attacks. Its features include noise-cancelling capabilities, cloud storage, AI-based analytics, clinical record integration, and an integrable mobile application. Founded in 2016, headquartered in Philadelphia, United States. Strados Labs operates in the Healthcare IT, Pulmonology, Disease Self Management, Wearable Technology sectors. The company focuses on Respiratory, Wheeze, Remot. The company has raised $6.4M in Series A funding. Notable investors include HAX, Ben Franklin Technology Partners, SOSV, Blu Venture Investors, Broad Street Angels, Wavemaker 360, among others.
Strados Labs
Series AProvider of a wearable device for breathing monitoring. It monitors the sound of the lungs and alerts the user of the wheezing sounds. This allows the user to manage their symptoms at an early stage and avoid the risk of asthma attacks. Its features include noise-cancelling capabilities, cloud storage, AI-based analytics, clinical record integration, and an integrable mobile application. Founded in 2016,…
About
Business model
Wearable Technology > Health and Wellness Devices > Respiratory,
Disease Self Management > Respiratory Diseases > Monitoring > Lung Health > Device > Wheeze,
Healthcare IT > Value Based Care > Remote Monitoring > Hardware > Wearables > Respiratory Health > Cough Monitoring,
Pulmonology > Medical Devices > Monitoring Devices > Lung Function Testing > Home Based > Spirometry,
SOSV Batches > HAX > Seed 2018,
MassChallenge Batches > HealthTech > 2021
Founders & team highlights
Serial Founder
Institutional investors
Latest coverage
📰 Latest funding news — recent raises and deal signals across the ecosystem.
Investor directory
🗂️ Explore HealthTech investors — funds that write checks in this sector.